“…Rasmussen encephalitis is the prototype of epileptic syndromes in which an immunopathogenesis is presumed, and reported favorable responses to immunomodulatory treatment support this hypothesis (reviewed in Billiau et al, 2005; Vezzani and Granata, 2005). Our Rasmussen patient showed high‐titer antinuclear antibodies, elevated total IgG and intrathecal oligoclonal Ig synthesis, which have previously been described (Andrews et al, 1990; Gaggero et al, 1990), but failed to respond and experienced the typical dramatic deterioration (Oguni et al, 1991). Some authors have reported that the clinical success rate of IVIG was higher in patients with IgA or IgG2 deficiency, although many other studies have refuted these associations (Ariizumi et al, 1983; Duse et al, 1986; Rijckevorsel‐Harmant et al, 1986; van Rijckevorsel‐Harmant and Delire, 1988; Spina et al, 1989; Illum et al, 1990; Sterio et al, 1990; Echenne et al, 1991; Rijckevorsel‐Harmant et al, 1994; van Engelen et al, 1994d).…”